Main content

A platform upgrade will be performed on the Atrium Institutional Repository from Monday, July 13 to Wenesday, July 15, 2020 (inclusive). During this time, users will not be able to submit new items to the Atrium. Users will still be able to browse, view, and download items that are already available in the Atrium. We apologize for any inconvenience this may cause.

Targeting energy metabolism in colorectal cancer

Show simple item record

dc.contributor.advisor Coomber, Brenda Ho, Nelson 2015-08-31T14:19:03Z 2015-08-31T14:19:03Z 2015-08 2015-08-20 2015-08-31
dc.description.abstract A switch to aerobic glycolysis regardless of oxygen tension is a metabolic phenotype observed in a variety of tumors, known as the Warburg effect, and is a possible target in cancer therapy. The abnormal tumor vasculature leads to a heterogeneous microenvironment with areas of hypoxia, acidity, and low nutrient supply. This thesis investigated the effects of the tumor microenvironment on the expression of glycolytic enzymes and on the efficacy of compounds targeting them. The first set of experiments examined the molecular and metabolic changes associated with dichloroacetate-induced cytoprotection in different human colorectal cancer (CRC) cell lines under anoxic conditions. There was evidence of differential regulation of pyruvate dehydrogenase phosphorylation between different cells leading to altered mitochondrial activity following dichloroacetate exposure. Hexokinase II (HKII) is a glycolytic enzyme often upregulated in tumors. 3-bromopyruvate (3BP) is an alkylating agent that shows promising anti-cancer effects in various cancer models and HKII has been suggested to be one of its principal targets. The efficacy of 3BP against CRC cells was assessed under different media glucose concentrations, and it was determined that 3BP was effective in reducing cell growth through alterations in AKT signaling and that media glucose availability played a role in cytotoxic sensitivity to 3BP. However, knockdown in HKII expression did not alter 3BP sensitivity in different CRC cell lines. Finally, HKII expression was assessed in colorectal cancer tissues and correlated with clinical parameters and patient outcome. Dual immunofluorescence was used to co-localize HKII with a marker of ischemia, carbonic anhydrase IX in 60 cases of human CRC. HKII expression was found only in non-ischemic areas of the tumors. While HKII expression did not correlate with any measured clinicopathlogical characteristics, patients with low HKII-expressing tumors had a worse prognosis than those with high HKII-expressing tumors. Overall, this thesis presents the effects of the tumor microenvironment on both glycolytic enzyme expression and therapeutic efficacy. This research promises to improve our understanding of tumor metabolism in the heterogeneous microenvironment in order to better apply this field of cancer biology for therapeutic use. en_US
dc.description.sponsorship CIHR, OGS, OVC, NSERC, CCS en_US
dc.language.iso en en_US
dc.rights Attribution-NonCommercial 2.5 Canada *
dc.rights.uri *
dc.subject colorectal cancer en_US
dc.subject metabolism en_US
dc.subject cell death en_US
dc.subject immunofluorescence en_US
dc.subject western blot en_US
dc.subject Warburg effect en_US
dc.subject 3-bromopyruvate en_US
dc.subject dichloroacetate en_US
dc.subject hexokinase en_US
dc.title Targeting energy metabolism in colorectal cancer en_US
dc.type Thesis en_US Biomedical Sciences en_US Doctor of Philosophy en_US Department of Biomedical Sciences en_US
dc.rights.license All items in the Atrium are protected by copyright with all rights reserved unless otherwise indicated.

Files in this item

Files Size Format View
Ho_Nelson_201508_PhD.pdf 2.929Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial 2.5 Canada Except where otherwise noted, this item's license is described as Attribution-NonCommercial 2.5 Canada